Dr. Fred Appelbaum, Executive Vice President of Fred Hutch Cancer Center, joins Green Bay Oncology physicians Dr. Brian Burnette, Dr. Kamal Abbi, and Dr. Evan Wenig, along with Dr. Brian Merkel, Professor and Chair of Human Biology at the University of Wisconsin–Green Bay. Together, they discuss how the patient experience of leukemia treatment has changed—and where it’s headed. From the psychological toll of isolation to the groundbreaking role of artificial intelligence in drug design, this conversation explores how clear communication, family support, and scientific persistence are giving new hope to patients and their families.

“Transplantation is a family affair. It is not something that patients go and do by themselves. It involves everyone, and it is getting safer and safer.”
— Dr. Fred Appelbaum

On this episode of Cancer Covered, you will learn:

Why patients can feel isolated: Many patients, especially young adults, experience emotional isolation during treatment. The doctors discuss why this happens and how families can help close that gap.
The importance of self-advocacy: Patients are encouraged to ask questions, speak up, and act as their own advocates so they feel informed and comfortable at every stage of care.
How doctors communicate complex information: Physicians often rely on analogies and repeated explanations—what they call “continuous education”—to help patients absorb difficult information during stressful moments.
What’s next in cellular therapy: Transplant research laid the foundation for CAR-T cell therapy. Today, artificial intelligence is being used to design new drugs that may one day cure autoimmune diseases—and even HIV.

This episode is the second of a three-part series. Listen to the rest of the conversation here: